The design and rationale for the APEX study (Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban)

The design and rationale for the APEX study (Acute Medically Ill VenousThromboembolismPrevention with ExtendedDuration Betrixaban)Alexander T. Cohen MD, Robert Harrington MD, Samuel Z. GoldhaberMD, Russell Hull MD, C. Michael Gibson MD, Adrian F. Hernandez MD,MHS, Michael M. Kitt MD, Todd J. Lorenz MDPII: S0002-8703(13)00786-2DOI: doi: 10.1016/j.ahj.2013.11.006Reference: YMHJ 4504To appear in: